- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01459731
Optical Coherence Tomography (OCT) Data Collection Study
May 1, 2012 updated by: Optovue
Optical Coherence Tomography Data Collection Study
Collect OCT data to evaluate the range and age trend of eye measurements.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Anticipated)
400
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
England
-
London, England, United Kingdom, EC1V 9EL
- Institute of Ophthalmology, University College London
-
-
-
-
California
-
Fullerton, California, United States, 92831
- Southern California College of Optometry
-
Pomona, California, United States, 91766
- College of Optometry, Western University of Health Sciences
-
San Jose, California, United States, 95112
- Buena Vista Eye Care
-
-
Illinois
-
Chicago, Illinois, United States, 60616
- Illinois Eye Institute
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
No eye disease
Description
Inclusion Criteria:
- At least 18 years of age
- Able and willing to provide consent
- Able and willing to complete the required examininations and visit
- Refractive error within 8 diopters sphere and within 2 diopters cylinder in each eye
- Best corrected visual acuity of 20/30 or better in each eye
Exclusion Criteria:
- History of leukemia, AIDS, dementia or multiple sclerosis
- Concomitant use of hydroxycloroquine or chloroquine
- Family history of glaucoma among first degree relatives
- Intraocular pressure of 22mm Hg or greater in either eye
- Unreliable or abnormal visual field
- Active ocular disease
- Previously diagnosed with glaucoma or glaucoma suspect
- Congenital ocular abnormalities
- Previous intra-ocular surgery or laser treatment (other than refractive surgery or uncomplicated cataract surgery greater than 6 months previously)
- Anatomic narrow angle
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Age 18-29
|
|
Age 30-39
|
|
Age 40-49
|
|
Age 50-59
|
|
Age 60-69
|
|
Age 70+
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
range of eye measurements
Time Frame: Day 1
|
Day 1
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
age trend of eye measurements
Time Frame: Day 1
|
Day 1
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: George Comer, OD, MBA, Southern California College of Optometry at Marshall B. Ketchum University
- Principal Investigator: Michael Chaglasian, OD, Illinois Eye Institute
- Principal Investigator: Jorge Cuadros, OD, PhD, Buena Vista Eye Care
- Principal Investigator: David Garway-Heath, MD, Institute of Ophthalmology, University College London
- Principal Investigator: Pinakin G Davey, OD, PhD, Western University of Health Sciences
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2011
Primary Completion (Actual)
March 1, 2012
Study Completion (Actual)
March 1, 2012
Study Registration Dates
First Submitted
October 23, 2011
First Submitted That Met QC Criteria
October 24, 2011
First Posted (Estimate)
October 26, 2011
Study Record Updates
Last Update Posted (Estimate)
May 2, 2012
Last Update Submitted That Met QC Criteria
May 1, 2012
Last Verified
May 1, 2012
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- OCT 200-47091
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on No Eye Disease
-
Assistance Publique - Hôpitaux de ParisURC-CIC Paris Descartes Necker CochinCompleted
-
Assistance Publique - Hôpitaux de ParisURC Necker Cochin, FranceCompleted
-
Turtle Shell Technologies Pvt. Ltd.Eastside Research AssociatesRecruitingNo Specific Medical Conditions or Disease States | No Specific ConditionsUnited States
-
University Hospitals Coventry and Warwickshire...Not yet recruiting
-
Yonsei UniversityRecruitingNo Restriction on DiseaseSouth Korea
-
National Cancer Institute (NCI)Completed
-
Topcon Medical Systems, Inc.CompletedNormal Healthy Subjects With No Known Ocular Diseases | Glaucomatous Eyes | Eyes With Retinal DiseasesUnited States
-
Topcon Medical Systems, Inc.CompletedNormal Healthy Subjects With No Known Ocular Diseases | Glaucomatous Eyes | Eyes With Retinal DiseasesUnited States
-
BEIJING YUANBEN INFORMATION CONSULTING CO., LTDCompletedNo Protrusion | No Open Wound | No Severe Allergic Reaction | No Scar | No Tattoo | No Significant Skin DefectChina